CoverageForm 410-K10-Q8-K13D13G13F

CNMD Conmed Corp - 8-K

Filed Mar 13, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001213900-26-027658
5.02

Item 5.02 - Departure/Election of Directors or Certain Officers

224 words

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 13, 2026, CONMED Corporation (the “Company”) announced
that Andrew Moller, age 51, will be appointed Interim Principal Financial Officer of the Company effective March 15, 2026.

Mr. Moller joined the Company in January 2025 as Vice President,
Corporate Controller and was appointed as the Company’s Principal Accounting Officer in April 2025. Prior to joining the
Company, he was employed by Smith & Nephew from May 2019 to December 2024, where he most recently served as Global Controller
and CFO Asia-Pacific. Prior to those roles, Mr. Moller served in a variety of roles at Stanley Black & Decker from 2011 to 2019,
including Director of Internal Audit. Mr. Moller is a certified public accountant, and he holds a Master of International Business
Studies from the University of South Carolina and a Bachelor of Science degree in Business Administration from the College of
Charleston.

There are no related-party transactions that would be required to
be disclosed under Item 404(a) of Regulation S-K with respect to Mr. Moller. There are no family relationships between Mr. Moller and
the members of the Company’s Board of Directors. There was no change to Mr. Moller’s compensation arrangements in connection with his
appointment as Interim Principal Financial Officer.

1